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Yuming Zhao1,2, Rita Fishelevich1, John P. Petrali3, Lida Zheng1, Malinina Alla Anatolievna1, April Deng1,
Richard L. Eckert1,4 and Anthony A. Gaspari1
PKCz (protein kinase C-z), a member of protein kinase C family, plays an important role in cell proliferation,
differentiation, and apoptosis. It acts as a downstream molecule for TNF-a (tumor necrosis factor) signal
transduction and also regulates the expression of CD1d, an HLA-class I-like molecule. The interaction of CD1d
with natural killer T (NKT) cells has been shown to be important in their Th1 cytokine production in psoriasis. In
this study, we examined PKCz in psoriasis in order to define its role in the pathogenesis of the disease. We
found that T-cell receptor (TCR) Va24þVb11þ NKT cells and CD1d molecules within psoriatic skin were
increased. Moreover, there was an associated increase in PKCz mRNA and protein expression with membrane
translocation in psoriasis lesions compared to uninvolved skin. Furthermore, cultured keratinocytes exhibited
increased PKCz activity and membrane translocation upon stimulation by TNF-a, a cytokine known to play an
important role in the pathogenesis of psoriasis. These results implied that PKCz is an important transduction
molecule downstream of TNF-a signaling and is associated with increased expression of CD1d that may
enhance CD1d–NKT cell interactions in psoriasis lesions. This makes PKCz a tempting target for possible
pharmacological intervention in modifying the downstream effects of TNF-a in psoriasis.
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INTRODUCTION
Psoriasis is a chronic inflammatory skin disorder
characterized by erythematous plaques with silvery scales.
Histologically, the lesions exhibit proliferation of epidermal
keratinocytes (KCs), inflammatory cell infiltration, and
increased angiogenesis of the superficial dermal vessels
(Gaspari, 2006). There is evidence suggesting that infiltration
of inflammatory cells, especially T lymphocytes, plays a
major role in the development of the lesions in predisposed
individuals, as the pathology develops following infiltration
of lymphocytes and the Th1 cytokines they release, for
example, IFN-g and tumor necrosis factor-a (TNF-a) (Krueger
and Bowcock, 2005; Gaspari, 2006; Lowes et al., 2007).
Other immune cells, such as natural killer T (NKT) cells,
dendritic cells, and a recently defined population of CD4þ T
cells, Th17 cells, are increasingly recognized to contribute to
or may even play a major part in the pathogenesis of the
disease. The role of T cells and the cytokines in the
pathogenesis of psoriasis is illustrated clinically by improve-
ment of lesions after administration of cyclosporin to inhibit
T-cell cytokine production, or the use of new biologicals to
interfere with T-cell activation or to block the effects
of cytokines such as TNF-a (Nickoloff and Stevens, 2006).
A mouse xenograft model also demonstrated that T cells and
other immunocytes, including cells with NKT cell features,
from the blood or residing in the engrafted skin from the
patients can reproduce typical lesions in the psoriatic
engraftment (Nestle and Nickoloff, 2005).
NKT cells are cells of the innate immune system and have
important functions in immunological tolerance, infection,
anticancer immune response, and autoimmunity. NKT cells
have limited T-cell receptor (TCR) gene usage, TCR Va24,
and Vb11 in humans, and have the unique ability to release
promptly large quantities of cytokines of both Th1 and Th2
types upon recognition of glycolipid antigens presented in the
context of MHC class I-like molecule, CD1d (Godfrey et al.,
2004). Increased number of NKT cells in psoriasis lesions has
been reported in several recent studies, implicating them as
cells of possible pathogenic significance (Bonish et al., 2000;
Cameron et al., 2002; Vissers et al., 2004; Liao et al., 2006;
Ottaviani et al., 2006). Nickoloff and co-workers (Bonish
et al., 2000) demonstrated that psoriatic KCs overexpressed
CD1d and NKT cells can be activated to elaborate IFN-g
when cultured with CD1d overexpressing KCs. These results
provided a pathogenetic link between psoriatic KCs, which
overexpress CD1d and NKT cells infiltrating the lesions. NKT
ORIGINAL ARTICLE
2190 Journal of Investigative Dermatology (2008), Volume 128 & 2008 The Society for Investigative Dermatology
Received 28 June 2007; revised 1 February 2008; accepted 9 February 2008;
published online 3 April 2008
1Department of Dermatology, University of Maryland School of Medicine,
Baltimore, Maryland, USA; 2Department of Dermatology, the First Hospital of
China Medical University, Shenyang, China; 3Comparative Pathology Branch,
Comparative Medicine Division, US Army Medical Research Institute of
Chemical Defense, Aberdeen Proving Ground, Maryland, USA and
4Department of Biochemistry and Molecular Biology, University of Maryland
School of Medicine, Baltimore, Maryland, USA
Correspondence: Professor Anthony A. Gaspari, Department of Dermatology,
University of Maryland School of Medicine, 405 W. Redwood St., 6th Floor,
Baltimore, Maryland 21201, USA. E-mail: agasp001@umaryland.edu
Abbreviations: KC, keratinocyte; NF-kB, nuclear factor-kB; NKT, natural killer T;
PKCz, protein kinase C z; TNF, tumor necrosis factor
cells as cells of innate immunity are of particular interest in
view of the recent contentions that, rather than acquired
immunity, it is innate immunity that is central to the
pathogenesis of psoriasis (Bos, 2007). Therefore, studies on
NKT cells and their antigen-presenting molecule CD1d are
important in unraveling the role played by innate immunity in
general and NKT cells in particular in the pathogenesis
of psoriasis.
Protein kinase C-z (PKCz) is a member of the PKC family
and is involved in the signal transduction of TNF-a (Moscat
et al., 2006). There is little information on the activities of
PKCz in psoriasis despite numerous studies on TNF-a in
psoriasis. Our previous study has shown that PKCz regulated
CD1d mRNA expression and protein synthesis (Fishelevich
et al., 2006). The question of interest therefore is whether TNF-
a can initiate increased PKCz activity as the downstream signal
molecule, which, apart from relaying TNF-a signal to trigger a
cascade of cellular events leading to psoriatic pathology, may
also upregulate CD1d expression observed in psoriasis and
thus be important in modulating interactions between CD1d-
overexpressing KCs and the infiltrating NKT cells.
Therefore, in this report, changes in PKCz in psoriasis and
the mechanisms relating to its activation were studied. We
show that NKT cells within the hyperplastic psoriatic
epithelia are increased. Moreover, PKCz mRNA and protein
are increased in psoriasis lesions with membrane transloca-
tion of the phosphorylated form of PKCz compared with
uninvolved skin. Finally, primary KCs and HaCaT cells show
PKCz increase and membrane and nuclear translocation
upon stimulation by TNF-a. These results imply that PKCz is
an important signal transduction molecule downstream of
TNF-a stimulation, and also plays a role in the increased
CD1d expression and potential involvement in KC–NKT cell
interactions in psoriatic lesions.
RESULTS
Increased TCR Va24þVb11þ NKT cells in psoriasis
A number of studies have shown that NKT cells are
associated with psoriatic lesions, including early, active,
and relapsing lesions (Bonish et al., 2000; Cameron et al.,
2002; Vissers et al., 2004; Liao et al., 2006; Ottaviani et al.,
2006), although the exact role played by these cells is yet to
be defined precisely. We hypothesize that NKT–KC interac-
tions could be involved in the pathogenesis in psoriasis.
Snap-frozen skin biopsy specimens were double-stained with
anti-CD2 and anti-Va24, or with anti-Va24 and anti-Vb11
mAbs. Va24þCD2þ or Va24þVb11þ double positive
NKT cells were increased in psoriasis (4.7 NKT cells per
millimeter of linear epidermis, n¼7, Po0.0001) compared
with healthy adult skin (0.3 NKT cell per millimeter, n¼ 6)
(Figure 1). All Va24- or Vb11-positive cells were also positive
for both markers. Although Va24þCD2þ double positive
NKT cells were present in both epidermal and dermal
compartments in psoriasis, the epidermis is the dominant
compartment showing an enrichment of NKT cells compared
with the dermis. We next sought to confirm whether the
NKT cells in psoriasis observed by immunohistochemistry
expressed the Va24-JaQ chain, a unique combination
characteristic of the ‘‘classical, invariant’’ NKT cells (Norris
et al., 1999). Indeed, in all six psoriasis plaques, but not in the
corresponding uninvolved skin examined, Va24-JaQ was
increased, both by nested PCR (not shown) and real-time PCR
(Figure 2) (Po0.05). These data confirmed at the transcript
level that NKT cells were increased in psoriasis plaques than
in uninvolved skin of these patients. The expression of CD1d
was more extensive in psoriasis, spanning much of the full
thickness, by immunohistochemistry, whereas in normal skin
CD1d was expressed in the upper epidermis (data not
shown). When skin from the six patients were assessed by
quantitative real-time PCR, CD1d transcripts were increased
in psoriatic plaques for more than 2- to 7-fold (Po0.05)
compared with uninvolved skin from each of the six patients
(Figure 3).
Increased PKCf in psoriasis
PKCz is required for TNF-a signaling and nuclear factor-kB
(NF-kB) activation (Moscat et al., 2006), both important in the
pathogenesis of psoriasis (Schottelius et al., 2004; Lizzul
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Figure 1. NKT cells increased in psoriasis. (a) Increase of Va24þVb11þ
double positive NKT cells in the epidermis of a psoriatic plaque. All
Va24-positive cells in psoriasis were also Vb11-positive. The isotype controls
were negative and Va24 and Vb11 single labeling showed no isotype
cross-reactivity (not shown). (b) CD2þVa24þ double positive NKT cells
(merge), as well as Va24 (red) or CD2 (green) single positive cells, in the
psoriatic epidermis and dermal papilla. Bar¼ 10mm.
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Figure 2. Infiltrating lymphocytes in psoriatic plaques express increased
invariant Va24-JaQ transcripts. Relative Va24-JaQ gene expression was
measured using real-time PCR to analyze gene expression from six psoriasis
(lesional and paired uninvolved skin). There is significant increase in
relative Va24-JaQ gene expression in psoriasis lesions (Po0.05, Wilcoxon
signed-rank test). Values are mean±SD, error bar¼1 SD.
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et al., 2005). We have shown that in KCs (Fishelevich et al.,
2006) and monocytes (our unpublished data), CD1d expres-
sion after cytokine stimulation was associated with increase
in PKCz activity, and CD1d expression at both mRNA and
protein levels could be reduced by inhibiting PKCz activity.
We speculated that, as a result of TNF-a stimulation, there
could be increased PKCz activity, which might be an
underpinning factor for the increase in CD1d expression on
KCs in psoriasis. We therefore examined fresh and archival
tissues of psoriasis for evidence of increased PKCz expression.
Immunofluorescence of snap-frozen samples for PKCz in
psoriasis specimens (n¼6) not only showed more extensive
and stronger cytoplasmic staining spanning almost the full
thickness of the hyperproliferative epithelia, but also a
distinct membrane staining pattern, which colocalized with
HLA-ABC antigen, compared with normal controls (n¼ 5)
(Figure 4a and b). The epidermis of normal skin is moderately
positive for PKCz with a cytoplasmic staining pattern, mainly
in the upper epidermis (n¼ 5). PKCz gene expression was
assayed using a quantitative real-time PCR in six pairs of
psoriasis plaques and uninvolved skin, and was found to be
increased significantly in all the psoriasis samples compared
with the corresponding uninvolved skin (Po0.05) (Figure 4c).
To further compare the differences of PKCz in psoriasis,
western blot analysis of paired lysates from diseased and
uninvolved skin (n¼ 6) was performed for PKCz and its
activated form, phospho-PKCz, but no statistically significant
differences in PKCz or phospho-PKCz were detected when
whole lysates were studied (Figure 5). Since activation of
PKCz is associated with translocation of the enzyme from
cytosol to the membrane (Nakanishi et al., 1993; Le Good
et al., 1998), we therefore examined the translocation of this
kinase to the membranes by ultracentrifugation fractionation
of whole-tissue lysates from these cases. Phospho-PKCz
reactivity was significantly increased in the membrane
(Po0.01) but not the cytosolic fractions of the diseased skin,
compared with their uninvolved counterparts (Figure 5).
These data suggest that PKCz is indeed activated in psoriatic
plaques, resulting in its translocation from the cytoplasm to
the plasma membrane.
TNF-a induces PKCf activation and translocation in KCs
TNF-a is a cytokine critical for the development of psoriasis
(Schottelius et al., 2004) and blockade of its activities with
biological agents can lead to remarkable improvement of
psoriatic skin lesions (Nickoloff and Stevens, 2006). TNF-a
requires PKCz as a downstream element in its signaling and it
has been shown to stimulate PKCz activity and translocation
in a variety of cell types (Esteve et al., 2002; Kim and Rikihisa,
2002; Lisby and Hauser, 2002). To better understand the role
played by TNF-a in PKCz increase in psoriasis lesions, we
* P<0.05
0
1
2
3
4
5
CD
1 
d 
re
la
tiv
e
 g
en
e
ex
pr
es
sio
n
*
Psoriasis
Uninvolved
Figure 3. CD1d gene expression is increased in psoriatic plaques.
Increased CD1d mRNA in psoriatic plaques was shown compared with
uninvolved skin in the six patients by real-time PCR (Po0.05, Wilcoxon
rank test). Values are mean±SD, error bar¼ 1 SD.
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Figure 4. Increased membrane expression of PKCf by psoriatic plaques.
(a) Immunofluorescence of PKCz in psoriasis and normal control skin showed
increased cytoplasmic and membrane staining for PKCz in psoriasis.
Bar¼10 mm. (b) Double labeling with anti-HLA-ABC antibody showed
membrane localization of PKCz in psoriasis lesion. (c) When mRNA from
six pairs of both lesional and uninvolved skin specimens was examined by
real-time PCR, PKCz gene expression was increased in all psoriasis samples
compared with uninvolved skin (Po0.05, Wilcoxon rank test). Values are
mean±SD, error bar¼1 SD.
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Figure 5. Increased phosphorylated PKCf in membrane fractions in psoriasis
plaques. Whereas no consistent difference was demonstrated in
phosphorylated PKCz in the whole lysates or in the cytosolic fractions of
psoriasis and their uninvolved skin (n¼ 6), the membrane fractions of
psoriasis lesions (L) showed significant increase in phospho-PKCz compared
with their uninvolved counterparts (N). Po0.01, Student’s t-test. Values
are mean±SD, error bar¼1 SD.
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studied cultured KCs for the effects of TNF-a stimulation in
the activation and translocation of this protein kinase.
Primary KCs showed increased expression of PKCz and
membrane staining by immunofluorescence by anti-PKCz
antibody after stimulation with TNF-a (not shown). Confocal
imaging showed increased membrane staining and increased
cytoplasmic and nuclear staining intensity of PKCz in KC after
TNF-a stimulation (Figure 6a–c). This membrane transloca-
tion and increased PKCz staining after TNF-a stimulation are
also corroborated by electron microscopy of immunoperoxi-
dase staining of KCs (not shown) and HaCaT (Figure 6d).
Immunoblotting of TNF-a-stimulated KC whole-cell lysates
showed no significant increase of either PKCz or phospho-
PKCz (Figure 7a). However, mitogen-activated protein kinase
(MAPK) pathway, known to be activated as a result of PKCz
signaling, was activated by such treatment in KCs as well as
in HaCaT (Figure 7a). This prompted us to investigate PKCz in
various cell fractions. As shown in Figure 7b, phospho-PKCz
was increased in both membrane and nuclear fractions of
KCs, whereas changes of phospho-PKCz in the cytosolic
fractions remained insignificant. These findings supported the
hypothesis that TNF-a is involved in the increased PKCz
activity and translocation in KCs.
DISCUSSION
There is considerable interest in NKT cells and their role in
the pathophysiology of psoriasis. Increased NKT cells were
consistently observed in psoriasis lesions by different groups
(Bonish et al., 2000; Cameron et al., 2002; Vissers et al.,
2004; Liao et al., 2006; Ottaviani et al., 2006). Experiments in
severe combined immunodeficient mice have also shown
that injection of human cells of NKT characteristics into
transplanted psoriatic skin could drive lesion development
(Nickoloff et al., 2000). Our present study showed increased
densities of NKT cells using a set of precise markers for
classical NKT cells, anti-Va24 and anti-Vb11 mAbs, in
psoriatic lesions, especially in the epidermis, compared with
healthy adult skin. CD1d molecules are HLA class I-like
molecules whose antigen-binding clefts hold and present
glycolipid antigens to NKT cells, which consequently release
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Figure 6. Increased PKCf and membrane translocation in KCs stimulated with TNF. (a) Confocal images: KCs cultured on coverslips stimulated with TNF-a
showed prominent membrane staining for PKCz (arrowheads) than the unstimulated cells (arrows at the dim cell boundaries). Bar¼ 10 mm. The picture is
representative of three separate experiments. (b) The cells with membrane staining were increased (48.9%) significantly in TNF-a-stimulated cells compared
with the medium alone (22.1%; Po0.01 by Fisher’s exact test). One hundred cells were counted for each condition. (c) The fluorescence staining intensity of
TNF-a stimulated cells increased significantly than those in medium alone. The intensities were measured by image analysis system of the fluorescence
micrographs. Po0.05, Student’s t-test. (d) Electron microscopic images of HaCaT on culture inserts stimulated with or without TNF-a, 100 ng ml1, for
10 minutes. Cell stimulated with TNF-a showed stronger staining (arrowheads) for PKCz in the plasma membrane as well as in the nuclear and perinuclear
areas apart from cytoplasmic staining, compared with unstimulated control cells. Note: N denotes nucleus. Bar¼ 1 mm.
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large quantities of cytokines and are of important immune
regulatory significance (Godfrey et al., 2004). Among the
cytokines released by activated NKT cells are IFN-g and
TNF-a, which are crucial in initiation and perpetuation of
psoriatic lesions. It has been shown that NKT cells can indeed
secrete IFN-g rather than IL-4 when co-cultured with KC
overexpressing CD1d (Bonish et al., 2000). These KCs may
form a basis for pathological interactions with NKT cells,
albeit in relative low numbers, infiltrating the psoriatic
epidermis. Such an interaction might act as a trigger for
NKT cytokine release, generating a cascade of events leading
to the pathology of psoriasis.
The study of regulation of CD1d expression is of
significance in the understanding of immunopathological
role of NKT cells in psoriasis. In our previous report
(Fishelevich et al., 2006), various factors regulating CD1d
expression were studied and we established that PKCz was an
important enzyme for CD1d expression in KCs. In this study,
we demonstrated that increased CD1d expression in psoriasis
lesions was associated with increased PKCz activation and
gene expression. This indicates that PKCz might be a crucial
kinase controlling of CD1d expression in psoriasis. There
have been similar reports showing the essential role PKCz
played in the expression of ICAM-1, which is also increased
in psoriatic plaques (Rahman et al., 2000). PKC is a family of
serine–threonine kinases with 11 members that can be
classified into three groups: conventional PKCs (including
a-, bI-, bII-, g-isoforms), novel PKCs (including d-, e-, Z-,
y-isoforms), and atypical PKCs (including z-, i-isoforms)
(Martelli et al., 2006; Moscat et al., 2006). PKCz is an
atypical isoform and regulates multiple cellular functions,
including proliferation and differentiation, cell-cycle regula-
tion, apoptosis, as well as tumorigenesis and autoimmunity
(Martelli et al., 2006; Moscat et al., 2006). PKCz is activated
by phosphorylation of threonine at 410 and is then
translocated to the plasma membrane or the nucleus (Martelli
et al., 2006). Phospho-PKCz can activate the MAPK pathway
and nuclear factor NF-kB (Duran et al., 2003; Moscat et al.,
2006). It has been shown that PKCz was increased in
squamous cell carcinoma and downregulation of PKCz could
inhibit cancer cell DNA synthesis and proliferation (Cohen
et al., 2006). In osteoarthritis, chondrocytes overexpressing
PKCz produced increased amount of cartilage-destructive
enzymes, whereas inhibition of PKCz activity could reduce
their production (LaVallie et al., 2006). PKCz is also crucial
for macrophage activation and expression of adhesion
molecule ICAM-1, and metalloprotease-9 (Rahman et al.,
2000; Esteve et al., 2002; Cuschieri et al., 2004). PKCz is
critical for CD1d expression in normal KCs and possibly its
overexpression in psoriatic lesions. In psoriasis, however,
PKCz has a broader role to play than CD1d expression
regulation, as it is important for signaling of TNF-a
(Schottelius et al., 2004). PKCz is one of the key downstream
mediators of TNF-a signaling through to NF-kB activation
and MAPK pathway in a variety of cell types (Berra et al.,
1995; Moscat et al., 2006). For example, PKCz is required for
DNA synthesis and proliferation of epithelial KCs of the oral
cavity via NF-kB and MAPK pathways (Cohen et al., 2006).
Inhibition of NF-kB and MAPK or their upstream signaling
mediator, PKCz, can reduce KC proliferation. In this report,
we further established that PKCz in KC was activated by
TNF-a and increased expression of this kinase in psoriasis
lesions may be the result of TNF stimulation on the KCs in
psoriatic epidermis. The effects of PKCz activation on
inflammation and KC proliferation in psoriasis are a topic
that warrants further study.
It has been proposed that psoriasis is a disease caused by
dysregulation of innate immunity, since TNF-a can be
produced abundantly by cells of this innate arm of the
immune system, such as macrophages, dendritic cells, and
NKT cells, and neither the psoriasis antigen(s) nor the specific
T cells for psoriasis have been identified unequivocally (Bos,
2007). Clinically, anti-TNF biological agents are highly
effective for psoriasis in a large proportion of patients
(Gaspari, 2006). The signal transduction of TNF-a to activate
NF-kB is essential for execution of the proinflammatory
effects by TNF, such as production of other inflammatory
cytokines and chemokines (IL-1, IL-6, IL-8, and so on), and
adhesion molecules, for example, ICAM-1 and VCAM, in the
epidermis and the endothelial cells (Wajant et al., 2003;
Schottelius et al., 2004). Increase in this activated phos-
phorylated form of NF-kB in psoriatic lesional KCs has been
demonstrated in a recent study (Lizzul et al., 2005), and such
elevated expression of NF-kB resumed to normal upon
clinical improvement by anti-psoriatic treatment with a TNF
blocker, etanercept. PKCz can activate NF-kB by phosphory-
lating RelA p65 protein (Duran et al., 2003), crucial for its
DNA binding after translocation into the nucleus. The DNA-
bound NF-kB subsequently switches on the transcription of a
host of important proinflammatory molecules (Schottelius
et al., 2004). In our previous study, we found that PKCz exerts
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Figure 7. Increased phosphorylated PKCf in membrane fractions of KCs
stimulated with TNF. (a) KCs were stimulated with 100 ng ml1 of TNF-a for
0, 2, 4, 6, 8, and 10 minutes. While no significant change in the quantity of
phospho-PKCz was observed, pERK and pJNK were increased 6 minutes after
TNF-a stimulation. (b) Increased phospho-PKCz in the membrane and
nuclear, but not in the cytosolic fractions, of primary KCs stimulated with
TNF-a 100 ng ml1 for 5 and 10 minutes (Student’s t-test). These blots are
representations of three separate experiments. Values are mean±SD,
error bar¼ 1 SD.
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its effects on CD1d synthesis also via NF-kB signaling
(Fishelevich et al., 2006). The concerted effects of these
molecules are activation of innate and acquired immunity,
proliferation of KCs, as well as angiogenesis, and thus
initiation and maintenance of psoriasis lesions.
In summary, in this study we found that there were
increased NKT cells and their lipid antigen-presenting
molecule CD1d within the psoriatic epidermis. Furthermore,
PKCz, which regulates CD1d expression, was increased in
psoriasis and such increase could be stimulated by TNF-a, a
cytokine critical in the pathogenesis of psoriasis. Taken
together, PKCz is critically located in the transduction
pathway from TNF-a to activate NF-kB, the event crucial
for the inflammatory process within the psoriasis lesions. This
makes PKCz an attractive target for pharmacological
intervention for psoriasis, with possibly more selective
inhibition of TNF-a effects.
MATERIALS AND METHODS
Reagents and antibodies
Anti-PKCz rabbit polyclonal antibody, anti-pJNK, and anti-pERK
mAbs were purchased from Santa Cruz Biotechnology Inc. (Santa
Cruz, CA); anti-phospho-PKCz rabbit polyclonal antibody was from
Cell Signaling Technology (Beverly, MA); anti-CD1d mAb was from
Biosource (Camarillo, CA); anti-TCR Va24 and anti-Vb11 mAbs
were from Immunotech (Fullerton, CA); and anti-CD2-phycoerythrin
or FITC mAbs, as well as goat anti-mouse IgG1 and IgG2a
biotinylated antibodies, were from BD Pharmingen (San Diego,
CA). Recombinant human TNF-a was purchased from Upstate
Biotechnology (Lake Placid, NY). Protease inhibitor cocktail and
phosphatase inhibitor cocktail were purchased from the Sigma
Company (St Louis, MO).
Patient specimens
Patients without systemic treatment and not using topical treatments
for at least 3 weeks were selected for the study after informed
consent. Skin samples were obtained by punch biopsy under local
lidocaine anesthesia. Psoriatic skin and uninvolved skin from 12
patients were homogenized and extracted for protein or RNA studies
(six cases each). An additional seven cases of psoriasis lesional skin
were collected for immunohistochemistry. Normal adult human skin
specimens were obtained from healthy adult undergoing plastic
surgery (n¼ 5). This study was reviewed and approved by the local
institutional review board at University of Maryland, Baltimore. It
followed the Declaration of Helsinki Principles for research
involving human subjects.
Primary KC and HaCaT cell line
Single-cell suspension of KCs for primary culture was prepared by
trypsinization of the epidermal sheets after separation from the
dermis by dispase digestion of newborn foreskins, with approval of
the local institutional review board. KCs were cultured in the
presence of low concentration of CaCl2 (0.05 mM) in Epi-Life growth
medium supplemented with epidermal growth factor and pituitary
extracts (Cascade Biologics, Portland, OR) at 37 1C with 5% CO2 in
air. The human KC cell line HaCaT was cultured in DMEM with 10%
fetal calf serum and antibiotics. For TNF-a stimulation study, KCs
were serum- or growth factor-starved overnight, and incubated with
TNF-a, 100 ng ml1, for the indicated times before protein or
RNA extraction.
Immunohistochemical procedures and confocal imaging
Frozen psoriasis samples were cut into 5-mm sections and fixed with
cold acetone for 10 minutes. Cultured primary KCs or HaCaT cells
were grown on coverslips and fixed with cold methanol for
10 minutes. PKCz was stained with rabbit polyclonal antibody by
indirect immunofluorescence for frozen sections, and cultured cells
on coverslips. For double immunofluorescence of NKT cells, frozen
sections were stained with primary antibody to TCR Va24 by indirect
immunofluorescence, followed by treatment with phycoerythrin- or
FITC-conjugated anti-CD2 mAb. NKT cells were also detected for
expression of both Va24 (IgG1) and Vb11 (IgG2a) using rhodamine-
conjugated goat anti-mouse IgG and goat-anti-mouse IgG subclass
antibodies and streptavidin–FITC. The staining was observed with
Nikon Eclipse E600 epifluorescence microscope equipped with a
digital camera. The images were documented using SpotTM imaging
system (Diagnostic Instruments, Sterling Heights, MI). For laser-
scanning confocal microscopy, stained cells on coverslips were
examined with an LSM 510, Axiovert 100 laser confocal microscope
(Zeiss, Carl Zeiss, Thornwood, NY) using an argon 458-nm laser for
green fluorescence.
Immunoelectron microscopy
Cultured primary human KCs or HaCaT cells were grown in
polyethylene terephthalate transparent inserts, pore size 0.4m. The
inserts were then fixed in cold methanol and incubated with rabbit
anti-human PKCz antibody (Santa Cruz Biotechnology Inc.), and
stained with Vectastain ABC immunoperoxidase procedure with
EliteTM ABC substrate (Vector Laboratories, Burlingame, CA). Cells
were then further fixed with 1/2 strength Karnovsky’s Fixative (1.6%
paraformaldehyde, 2.5% glutaraldehyde in 0.1 M sodium cacodylate
buffer). Following fixation, inserts were removed, post fixed in
buffered 1% osmium tetroxide, impregnated, and embedded in
epoxy resin (Polybed 812). Ultrathin epoxy sections (900 nm)
prepared with a LEICA Ultracut ICU were nonspecifically stained
with uranyl acetate and lead citrate, and analyzed with a JEOL
JEM 1230 transmission electron microscope at 60,000 accelerating
voltage.
Reverse transcription-PCR
Total RNAs from cultured KCs were prepared with the RNeasy kit
(Qiagen, Valencia, CA) as per manufacturer’s instructions. Psoriasis
samples were homogenized by Ultra-Turrax T8 homogenizer (IKA-
Werke, Staufen, Germany) and RNA was isolated. Synthesis of
cDNA was completed using standard methods. The expression of
Va24-JaQ TCR gene was examined using nested PCR amplification
technique as described previously (Norris et al., 1999). Briefly,
cDNA (1ml) isolated from purified NKT cells from healthy adult
peripheral blood (a generous gift from Dr D Unutmaz; Eger et al.,
2006), biopsies from psoriasis, and normal skin were first amplified
using Va24 (50-CACAAAGCAAAGCTCTCTGCACA) and Ca (50-GCC
ACAGCACTGTTGCTCTTG) primers to generate a 326-bp fragment.
The amplicons were amplified in the second round using Va24 and
JaQ (50-GAGTTCCTCTTCCAAAGTATAGCCT) primers, resulting in
amplification of the 119-bp Va24-JaQ fragment. The 18S gene was
also amplified in the same biopsy samples using an equivalent
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volume of cDNA and the following primers: 50-GTAACCCGTT
GAACCCCATT (sense) and 50-CCATCCAATCGGTAGTAGCG
(antisense). For all amplifications, one cycle at 94 1C for 60 seconds
followed by 30 cycles involving denaturation at 94 1C for
30 seconds, annealing at 56 1C for 40 seconds, and extension at
72 1C for 40 seconds were performed. The PCR products were
visualized by 1.5% agarose gel electrophoresis with ethidium
bromide staining.
Real-time PCR
Real-time PCR (LightCycler; Roche Applied Science, Indianapolis,
IN) was used to examine different levels of expression of selected
mRNA. The hybridization probes were labeled with fluorescein at
the 50 terminus (3FL) and with LightCycler Red at the 50 terminus of
the other probe. Amplification of a single PCR product was
confirmed by gel electrophoresis and melting-curve analyses. The
sequences of the sense, antisense, and internal hybridization probes
are as follows: 18S (sense), 50-AACCCGTTGAACCCCATT-30; 18S
(antisense), 50-CCATCCAATCGGTAGTAGCG-30; CD1d (sense),
50-AGACATGGTATCTCCGAGCAAC-30; CD1d (antisense), 50-CTG
AGCAGACCAGGACTGAA-30; FL-probe, 50-TAGTAGCTCCCACCC
CAGTAGAGGAC-FL-30; and LC-probe, 50-LC Red640-ATGTCCT
GGCCCTCTAGACTGCTGTGPH-30. After denaturation, cDNA
were subjected to 40–50 cycles of amplification, followed by
melting-curve analysis. For quantification of Va24-JaQ expression,
real-time PCR was performed using the LightCycler FastStart DNA
Master SYBR Green kit (Roche Applied Science) according to
manufacturer’s instructions, and using real-time PCR conditions for
18S quantification. PKCz real-time PCR was performed with Qiagen
QuantiTect Gene Expression Assay using Hs-PRKCZ Assay Mix. The
conditions recommended by the manufacturer were used, with an
initial activation step of 15 minutes at 95 1C, followed by denatura-
tion at 94 1C for 0 seconds, annealing/detection at 56 1C for
30 seconds, and extension at 76 1C for 30 seconds for 40–45 cycles.
Western blot
Cultured KCs were lysed by radioimmunoprecipitation assay buffer
with protease and phosphatase inhibitor cocktails (Sigma Company).
Psoriasis lesional and uninvolved skin or normal skin tissues were
homogenized in radioimmunoprecipitation assay buffer supplemen-
ted with protease and phosphatase inhibitor cocktails. The protein
concentration was measured by Lowry method. Equal quantities of
total proteins (usually 20–30 mg of proteins) were loaded on the 10%
Bis-Tris NuPage denaturing gel (Invitrogen Life Technologies,
Carlsbad, CA) for electrophoresis. Gels were transferred to nitro-
cellulose membranes and were probed with appropriate antibodies
and detected by WesternBreeze Chemiluminescent detection kit
(Invitrogen Life Technologies). The enhanced chemiluminescence
bands were detected using Chemi-Doc densitometer and Quantity-
One software (Bio-Rad, Hercules, CA). The intensity of the bands
was expressed in arbitrary units.
Cell fractionation
Cultured KCs were lysed in hypotonic buffer (10 mM Tris-HCl pH
7.5, 1.0 mM MgCl2, 10 mM KCl, 10 mM EDTA, 1.0 mM dithiothreitol,
1.0 mM Na3VO4, 100 protease and phosphatase inhibitor
cocktails) and centrifuged at 750 g for 10 minutes. The pellets
were collected as the nuclear fraction and the supernatants were
centrifuged at 100,000 g for 1 hour at 4 1C (Beckman Coulter,
Fullerton, CA). The supernatants were regarded as the cytosolic
fractions and the pellets were resuspended in the above hypotonic
buffer with 1% Triton X-100 (Sigma Company) before pulse
sonication (Sonic Dismembrator, Model 100; Fisher Scientific,
Waltham, MA). The resuspensions were incubated at 4 1C for
30 minutes before centrifugation at 20,000 g for 20 minutes. The
supernatants were collected as the plasma-membrane fractions.
Fresh psoriasis biopsies were cut into small pieces and homogenized
in radioimmunoprecipitation assay buffer, and then incubated with
rotation at 4 1C for 30 minutes before centrifugation at 20,000 g at
4 1C for 10 minutes. The supernatants were subjected to centrifuga-
tion at 100,000 g for 1 hour. The membrane and cytosolic fractions
were collected and the cell lysates or cell fractions were further
analyzed by western blotting with equal loading of the total proteins
in each lane in the same gel.
Statistical analysis
Quantitative and qualitative data were analyzed for statistically
significant differences between control and treatment groups by
t-test, Mann–Whitney rank-sum test, or w2-test using GraphPad InStat
software (Po0.05 was considered significant).
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